Skip to main content
British Medical Journal logoLink to British Medical Journal
letter
. 1964 Oct 31;2(5417):1135–1136. doi: 10.1136/bmj.2.5417.1135-d

Laevadosin for Muscular Dystrophy

W H S Thomson
PMCID: PMC1817010  PMID: 14198741

Full text

PDF
1135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FOWLER W. M., Jr, CHOWDHURY S. R., PEARSON C. M., GARDNER G., BRATTON R. Changes in serum enzyme levels after exercise in trained and untrained subjects. J Appl Physiol. 1962 Nov;17:943–946. doi: 10.1152/jappl.1962.17.6.943. [DOI] [PubMed] [Google Scholar]
  2. ROTTHAUWE H. W., CERQUEIRO-RODRIGUEZ M. DIE BESTIMMUNG DER SERUM-KREATINPHOSPHOKINASE IM OPTISCHEN TEST. Clin Chim Acta. 1964 Aug;10:134–143. doi: 10.1016/0009-8981(64)90157-3. [DOI] [PubMed] [Google Scholar]
  3. Richterich R., Rosin S., Aebi U., Rossi E. Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination. Am J Hum Genet. 1963 Jun;15(2):133–154. [PMC free article] [PubMed] [Google Scholar]
  4. THOMSON W. A. Sources of error in the biochemical diagnosis of muscular dystrophy. J Neurol Neurosurg Psychiatry. 1962 Aug;25:191–202. doi: 10.1136/jnnp.25.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. THOMSON W. H., GUEST K. E. A trial of therapy by nucleosides and nucleotides in muscular dystrophy. J Neurol Neurosurg Psychiatry. 1963 Apr;26:111–122. doi: 10.1136/jnnp.26.2.111. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES